Literature DB >> 15190260

Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during differentiation.

B Rocca1, R Morosetti, A Habib, N Maggiano, F Zassadowski, G Ciabattoni, C Chomienne, B Papp, F O Ranelletti.   

Abstract

Cyclooxygenase (COX)-1 or -2 and specific prostaglandin (PG) synthases catalyze the formation of various PGs. We investigated the expression and activity of COX-1 and -2 during granulocyte-oriented maturation induced by all-trans-retinoic acid (ATRA) of NB4 cells, originated from a human acute promyelocytic leukemia (APL), and in blasts from APL patients. The expression of COX isoenzymes or prostaglandin synthases was also investigated in circulating granulocytes and human bone marrow. COX-1 was expressed and enzymatically active in NB4 cells and primary blasts. COX-1 mRNA and protein were induced by ATRA. COX-1 protein increased approximately 2-3.5-fold by culture day 3 in NB4 cells and primary blasts, while basal COX-2 expression was very low and unaffected by ATRA. COX-1-dependent PGE(2) biosynthesis increased during differentiation approx. 5-fold. Indomethacin and the selective COX-1 inhibitor SC-560, but not selective COX-2 inhibition, impaired NB4 differentiation, reducing NADPH-oxidase activity, CD11b and CD11c expression. The immunohistochemistry of granulocytes and myeloid precursors in the bone marrow showed a large prevalence of COX-1 as compared to COX-2. In conclusion, COX-1 is induced during ATRA-dependent maturation and appears to contribute to myeloid differentiation both in vitro and ex vivo, and COX-1 activity may potentiate the differentiation of human APL.Leukemia (2004) 18, 1373-1379. doi:10.1038/sj.leu.2403407 Published online 10 June 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15190260     DOI: 10.1038/sj.leu.2403407

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  The regulation of normal and leukemic hematopoietic stem cells by niches.

Authors:  Meng-Meng Huang; Jiang Zhu
Journal:  Cancer Microenviron       Date:  2012-07-22

Review 2.  Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.

Authors:  Guang-Biao Zhou; Ji Zhang; Zhen-Yi Wang; Sai-Juan Chen; Zhu Chen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

3.  Lipid mediators and human leukemic blasts.

Authors:  Rémi Fiancette; Christelle Vincent-Fabert; Estelle Guerin; Franck Trimoreau; Yves Denizot
Journal:  J Oncol       Date:  2010-10-10       Impact factor: 4.375

4.  Staphylococcus aureus recognition by hematopoietic stem and progenitor cells via TLR2/MyD88/PGE2 stimulates granulopoiesis in wounds.

Authors:  Jennifer L Granick; Patrick C Falahee; Delsheen Dahmubed; Dori L Borjesson; Lloyd S Miller; Scott I Simon
Journal:  Blood       Date:  2013-07-18       Impact factor: 22.113

5.  Mesenchymal stem cells induce granulocytic differentiation of acute promyelocytic leukemic cells via IL-6 and MEK/ERK pathways.

Authors:  Fang Chen; Kang Zhou; Lei Zhang; Fengxia Ma; Dandan Chen; Junjie Cui; Xiaoming Feng; Shaoguang Yang; Ying Chi; Zhibo Han; Feng Xue; Lijuan Rong; Meili Ge; Li Wan; Shuxia Xu; Wenjing Du; Shihong Lu; Hongying Ren; Zhongchao Han
Journal:  Stem Cells Dev       Date:  2013-03-15       Impact factor: 3.272

Review 6.  Retinoic acid and arsenic for treating acute promyelocytic leukemia.

Authors:  Guang-Biao Zhou; Wei-Li Zhao; Zhen-Yi Wang; Sai-Juan Chen; Zhu Chen
Journal:  PLoS Med       Date:  2005-01       Impact factor: 11.069

7.  Characterization of proteins associating with 5' terminus of PGHS-1 mRNA.

Authors:  Natalia Bunimov; Odette Laneuville
Journal:  Cell Mol Biol Lett       Date:  2010-01-28       Impact factor: 5.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.